Latest News

Vodafone Idea’s decision to modernize its transport network with Ciena (CIEN) WaveLogic 6 Extreme coherent optical technology, including 1.6 Tb/s data center links in India, has put fresh focus on the stock’s role in AI era bandwidth demand. See our latest analysis for Ciena. That Vodafone Idea win lands at a time when Ciena’s share price has climbed 77.6% over the past 90 days and 68.8% year to date, while the 1 year total shareholder return is well over 5x. This points to strong momentum as...

Nanto Bank (TSE:8367) has raised its full year earnings guidance and year end dividend forecast after expecting higher net interest income and profit attributable to owners of parent for the 2026 fiscal year. See our latest analysis for Nanto Bank. The raised earnings and dividend guidance comes after a strong run, with a 23.57% 90 day share price return and a very large 5 year total shareholder return. However, the 1 day share price decline of 2.51% suggests some cooling after the news. If...

Guanze Medical Information Industry (Holding) (SEHK:2427) has reported its FY 2025 first half results with revenue of C¥31.9 million and basic EPS of C¥0.0036, set against trailing twelve month figures of C¥147.6 million in revenue and C¥0.0222 in EPS that reflect an 80.9% earnings increase over the last year. Over the past three reported half year periods, revenue has moved from C¥40.0 million in 1H 2024 to C¥115.7 million in 2H 2024 and then C¥31.9 million in 1H 2025, while EPS shifted from...

On March 31, 2026, MINISO Group Holding reported record fourth-quarter and full-year 2025 revenue growth but a sharp drop in profitability, completed a HK$632.51 million share buyback totaling 19,003,004 shares, and declared a final ordinary dividend of US$0.0941 per share for 2025 alongside an amended dividend policy targeting about 50% of adjusted net profit. The combination of strong sales momentum, increased impairments and weaker earnings, together with ongoing capital returns through...

Investors may be considering whether Cadence Design Systems at around US$280 per share still aligns with its underlying worth, or if expectations have run ahead of reality. The stock closed at US$280.19, with returns of a 0.4% decline over 7 days, 7.6% decline over 30 days, 9.7% decline year to date, 5.8% gain over 1 year, 35.0% gain over 3 years and 96.5% gain over 5 years. This presents a mixed picture of recent and longer-term performance. Recent news coverage has focused on Cadence...

Fuchs SE recently reported full-year 2025 results showing sales of €3,563 million and net income of €306 million, alongside 2026 guidance calling for around €3.7 billion in sales and €450 million in EBIT, supported in part by the planned full acquisition of its Turkish OPET joint venture. The company also proposed and later announced a 5% increase in the dividend to €1.23 per preference share, with the annual payout of €1.23 per share scheduled for payment on May 11, 2026, underlining a...

What Teva’s latest biosimilar milestones mean for investors Teva Pharmaceutical Industries (NYSE:TEVA) has just reported three key milestones in its biosimilar portfolio, including US Food and Drug Administration approval for PONLIMSI as a biosimilar to Prolia and regulatory progress on a proposed Xolair biosimilar. These product updates sit alongside a mixed share price backdrop, with the stock showing a 0.4% return over the past day and 2.7% over the past week, as well as declines over the...

Dassault Systèmes (ENXTPA:DSY) has drawn fresh attention after filing its 2025 Universal Registration Document and outlining a share repurchase program, along with a new long-term partnership with JSW Motors built around its 3DExperience platform. See our latest analysis for Dassault Systèmes. Despite the news around the Universal Registration Document, share repurchase plans, and the JSW Motors partnership, the 1-year total shareholder return of 50.23% and 5-year total shareholder return of...

What the latest earnings tell you about Osisko Development Osisko Development (TSXV:ODV) released full year 2025 results showing sales of CA$35.48 million versus CA$4.56 million a year earlier, alongside a wider net loss of CA$169.01 million and higher basic loss per share. See our latest analysis for Osisko Development. The earnings release appears to have sharpened investor focus on Osisko Development’s balance between higher sales and larger losses. The 1 day share price return of 3.1% and...

What recent returns tell you about Subsea 7 Subsea 7 (OB:SUBC) has drawn investor attention after a 2.4% decline over the past day, alongside gains of 8.1% over the past week and 10.3% over the past month. Those short term moves sit within a much stronger recent backdrop, with total return figures of 44.3% over the past 3 months and 94.8% over the past year, and a year to date return of 41.0%. See our latest analysis for Subsea 7. The recent 1 day share price decline sits against strong...

B2Gold (TSX:BTO) has renewed its normal course issuer bid, authorizing the repurchase of up to 10% of its shares. The updated buyback program gives the company flexibility to retire shares over the coming period, subject to market conditions and regulatory limits. Management highlights the program as a tool to return capital to shareholders when it views the share price as attractive. B2Gold operates as a gold producer, so its share price often tracks broad sentiment around precious metals,...

Pathward Financial (CASH) has drawn investor attention after recent share price moves, with the stock showing mixed short term returns and a stronger pattern over the past 3 months and year to date. See our latest analysis for Pathward Financial. The recent move to a share price of $90.02 comes after a 26.79% 90 day share price return and a 25.25% year to date share price return. The 3 year total shareholder return of 120.58% points to a stronger longer term trend. If you are comparing...

Globalstar stock snapshot after recent price move Globalstar (GSAT) has drawn fresh attention after a recent daily gain of about 3.2%, adding to its month and past 3 months returns. That move invites a closer look at its current fundamentals. See our latest analysis for Globalstar. Beyond the latest move, Globalstar’s 30 day share price return of 10.53% and 90 day share price return of 12.27% sit alongside a very large 1 year total shareholder return, suggesting momentum has been building...

Protector Forsikring (OB:PROT) has been added to the Oslo OBX Total Return Index, a move that can increase visibility among institutional investors and index trackers that follow Norway’s flagship benchmark. See our latest analysis for Protector Forsikring. The latest inclusion comes after a softer patch for the shares, with a 30 day share price return of 7.54% and a year to date share price return of 10.56%. However, the 1 year total shareholder return of 40.39% and very large 5 year total...

Wondering if Insmed's current share price lines up with its underlying worth, or if the recent excitement has moved it away from fair value? The stock recently closed at US$164.86, with returns of 11.7% over 7 days, 12.1% over 30 days, a 6.9% decline year to date, and very large gains over 1 year and 3 years that may change how you think about risk and reward. Recent headlines have focused on Insmed's progress as a biotech player, with attention on its pipeline developments and regulatory...

In late March 2026, Zoetis Inc. participated in the World Vaccine Congress in Washington, while also scheduling a May webcast and call to review its first-quarter 2026 financial results with investors. A separate development saw Bristol Gate Capital Partners exit its long-held Zoetis position, citing slowing dividend growth, setbacks for key osteoarthritis drug Librela, and rising competitive pressures in core product categories. Against this backdrop, we’ll now examine how concerns over...

If you are wondering whether Palantir Technologies is still priced for big expectations or has already run too far, the next sections focus squarely on what the current share price might imply about value. The stock last closed at US$146.49, after a 5.5% decline over the past week, a 0.9% gain over the past month, a 12.7% decline year to date, and a 67.5% return over the past year, with a very large gain over three and five years. Recent coverage has continued to focus on Palantir's role in...

Airbus (ENXTPA:AIR) completed a successful flight test of its Bird of Prey interceptor drone. The system engaged a missile target as an autonomous, cost-focused defense against kamikaze drones. The trial marks the operational debut of this counter UAV solution, with further tests planned. For investors following ENXTPA:AIR, this Bird of Prey milestone adds another element to Airbus's broader profile across commercial aircraft, helicopters, and defense systems. The test highlights how drone...

Century Aluminum (CENX) is back in focus after a series of supply shocks in the global aluminum market and company specific moves, including a new Oklahoma smelter joint venture and recent asset reshuffling. See our latest analysis for Century Aluminum. The recent surge in Century Aluminum’s share price, including a 26.54% 7 day share price return and a very large 3 year total shareholder return, reflects rising interest after supply disruptions, Oklahoma smelter plans, and upgraded outlooks...

If you are wondering whether Adient's current share price gives you genuine value or just noise, starting with how the market has treated the stock recently can offer useful clues. Adient has seen a 2.8% decline over the past week and an 11.7% decline over the past month, although the shares are still up 9.4% year to date and 62.5% over the last year, with longer 3 year and 5 year returns of 45.7% and 50.5% declines respectively. These moves sit against an evergreen backdrop where investors...

Frontline plc recently confirmed that Director Richard C. Prince resigned from the board, as the company also released its audited 2025 annual report outlining performance and governance developments. At the same time, heightened tensions in the Middle East are disrupting key oil shipping lanes, tightening tanker supply and lifting charter rates for operators of Very Large Crude Carriers such as Frontline. We’ll now examine how tighter tanker availability amid Middle East tensions could...

Why Vår Energi (OB:VAR) is on investors’ radar today Recent share price moves in Vår Energi (OB:VAR), including a 4.7% decline over the past day and gains over the past month and past 3 months, have drawn fresh investor attention. See our latest analysis for Vår Energi. That 4.7% one day share price decline comes after a strong run, with a 30 day share price return of 27.9% and a 1 year total shareholder return of 67.6%. This points to momentum still building rather than fading as investors...

KalVista Pharmaceuticals (KALV) is back in focus after releasing interim KONFIDENT-KID data on EKTERLY, its oral hereditary angioedema treatment for children, showing effective on demand use and a favorable tolerability profile. See our latest analysis for KalVista Pharmaceuticals. The KONFIDENT-KID update lands after a busy stretch for KalVista, with earnings in late March showing an eight month net loss of US$109.52 million and the share price now at US$19.77. This is supported by a 30 day...

If you are wondering whether Allegro MicroSystems at around US$33.30 still offers value or is starting to look expensive, you are in the right place. The stock has returned 2.1% over the last 7 days, while the 30 day return is a 9.0% decline, with longer term figures of 23.7% year to date, 28.5% over 1 year, 27.0% over 3 years and 21.4% over 5 years. Recent moves in Allegro MicroSystems' share price sit against a backdrop of ongoing interest in semiconductor names and shifting expectations...